Literature DB >> 31562554

Usefulness of pre- and post-stent optical frequency domain imaging findings in the prediction of periprocedural cardiac troponin elevation in patients with coronary artery disease.

Kenichiro Otsuka1, Kenei Shimada2, Hirotoshi Ishikawa3, Haruo Nakamura3, Hisashi Katayama3, Hisateru Takeda3, Kohei Fujimoto3, Noriaki Kasayuki3, Minoru Yoshiyama4.   

Abstract

Cholesterol crystals (CCs) are frequently found in high-risk plaques, such as thin-capped fibroatheromas. The purpose of this study was to investigate the associations of CCs, plaque morphologies, and post-stent optical frequency domain imaging (OFDI) findings with periprocedural cardiac troponin (cTn) elevation in patients treated with percutaneous coronary intervention (PCI). This study consists of 119 patients with stable coronary artery disease (CAD) with normal cTn levels who underwent OFDI-guided PCI. Periprocedural cTn elevation was defined as an elevation of cTn ≥  × 5 times the upper reference limit after PCI. Pre- and post-stent OFDI findings, including fibrous cap thickness (FCT), presence of CCs, and parameters for lipid and calcification were analyzed. A total of 37 (31%) patients were classified into the periprocedural cTn elevation group. Compared with lesions without CCs, lesions exhibiting CCs had thinner FCT, larger lipid arc, and longer lipid length, and were more likely to have irregular protrusion and in-stent thrombus (all p < 0.05). For pre-stent OFDI features, FCT < 82 µm [odds ratio (OR) 4.11; p = 0.003] and CCs (OR 3.23; p = 0.017) were associated with periprocedural cTn elevation. For post-stent OFDI features, in-stent dissection (OR 3.08; p = 0.035) and in-stent thrombus (OR 7.98; p = 0.002) were independent predictors of cTn elevation. The combination of CCs and FCT < 82 µm showed increased risk of periprocedural cTn elevation (OR 7.22; p = 0.002). OFDI-guided PCI provides unique insight into the mechanism for periprocedural cTn elevation in CAD patients.

Entities:  

Keywords:  Cardiac troponin; Cholesterol crystal; Myocardial infarction; Optical frequency domain imaging; Percutaneous coronary intervention

Mesh:

Substances:

Year:  2019        PMID: 31562554     DOI: 10.1007/s00380-019-01512-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  34 in total

1.  Insulin resistance is associated with coronary plaque vulnerability: insight from optical coherence tomography analysis.

Authors:  Tomokazu Iguchi; Takao Hasegawa; Kenichiro Otsuka; Kenji Matsumoto; Takanori Yamazaki; Satoshi Nishimura; Shinji Nakata; Shoichi Ehara; Toru Kataoka; Kenei Shimada; Minoru Yoshiyama
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-09-09       Impact factor: 6.875

2.  Incidence, factors, and clinical significance of cholesterol crystals in coronary plaque: An optical coherence tomography study.

Authors:  Kazuhiro Fujiyoshi; Yoshiyasu Minami; Kohki Ishida; Ayami Kato; Aritomo Katsura; Yusuke Muramatsu; Toshimitsu Sato; Ryota Kakizaki; Teruyoshi Nemoto; Takuya Hashimoto; Nobuhiro Sato; Kentaro Meguro; Takao Shimohama; Taiki Tojo; Junya Ako
Journal:  Atherosclerosis       Date:  2019-02-14       Impact factor: 5.162

3.  Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes.

Authors:  George S Abela; Kusai Aziz; Ameeth Vedre; Dorothy R Pathak; John D Talbott; Joyce Dejong
Journal:  Am J Cardiol       Date:  2009-02-07       Impact factor: 2.778

4.  Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography.

Authors:  Roshan Patel; Abed Janoudi; Ameeth Vedre; Kusai Aziz; Umesh Tamhane; Jack Rubinstein; Oliver G Abela; Kevin Berger; George S Abela
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-04       Impact factor: 8.311

5.  Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography.

Authors:  Italo Porto; Luca Di Vito; Francesco Burzotta; Giampaolo Niccoli; Carlo Trani; Antonio M Leone; Luigi M Biasucci; Rocco Vergallo; Ugo Limbruno; Filippo Crea
Journal:  Circ Cardiovasc Interv       Date:  2012-01-31       Impact factor: 6.546

6.  Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study.

Authors:  Lei Xing; Takumi Higuma; Zhao Wang; Aaron D Aguirre; Kyoichi Mizuno; Masamichi Takano; Harold L Dauerman; Seung-Jung Park; Yangsoo Jang; Chong-Jin Kim; Soo-Joong Kim; So-Yeon Choi; Tomonori Itoh; Shiro Uemura; Harry Lowe; Darren L Walters; Peter Barlis; Stephen Lee; Amir Lerman; Catalin Toma; Jack Wei Chieh Tan; Erika Yamamoto; Krzysztof Bryniarski; Jiannan Dai; Thomas Zanchin; Shaosong Zhang; Bo Yu; Hang Lee; James Fujimoto; Valentin Fuster; Ik-Kyung Jang
Journal:  J Am Coll Cardiol       Date:  2017-05-23       Impact factor: 24.094

7.  The impact of circulating cholesterol crystals on vasomotor function: implications for no-reflow phenomenon.

Authors:  Nitesh Gadeela; Jack Rubinstein; Umesh Tamhane; Ruiping Huang; Dorothy R Pathak; Hazel-Ann Hosein; Michael Rich; Gaurav Dhar; George S Abela
Journal:  JACC Cardiovasc Interv       Date:  2011-05       Impact factor: 11.195

8.  High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.

Authors:  Rikuta Hamaya; Tomoki Horie; Taishi Yonetsu; Akinori Sugano; Yoshihisa Kanaji; Eisuke Usui; Masahiro Hoshino; Masao Yamaguchi; Hiroaki Ohya; Yohei Sumino; Masahiro Hada; Hidenori Hirano; Yoshinori Kanno; Haruhito Yuki; Kenzo Hirao; Tsunekazu Kakuta
Journal:  Heart Vessels       Date:  2019-01-01       Impact factor: 2.037

Review 9.  Coronary microembolization.

Authors:  Gerd Heusch; Rainer Schulz; Michael Haude; Raimund Erbel
Journal:  J Mol Cell Cardiol       Date:  2004-07       Impact factor: 5.000

10.  Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts.

Authors:  Kirsten Leineweber; Dirk Böse; Magdalene Vogelsang; Michael Haude; Raimund Erbel; Gerd Heusch
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.